Interpace Biosciences, Inc. (IDXG)
6.025
-0.36
(-5.71%)
USD |
OTCM |
Oct 02, 16:00
Interpace Biosciences Cash from Operations (TTM) : 4.457M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 4.457M |
| March 31, 2026 | 4.879M |
| December 31, 2025 | 5.831M |
| September 30, 2025 | 4.877M |
| June 30, 2025 | 5.055M |
| March 31, 2025 | 5.939M |
| December 31, 2024 | 4.646M |
| September 30, 2024 | 4.602M |
| June 30, 2024 | 3.591M |
| March 31, 2024 | 2.598M |
| December 31, 2023 | 3.789M |
| September 30, 2023 | 2.373M |
| June 30, 2023 | -1.976M |
| March 31, 2023 | -5.305M |
| December 31, 2022 | -7.692M |
| September 30, 2022 | -8.634M |
| June 30, 2022 | -6.084M |
| March 31, 2022 | -5.09M |
| December 31, 2021 | -8.842M |
| September 30, 2021 | -9.208M |
| June 30, 2021 | -14.24M |
| March 31, 2021 | -11.86M |
| December 31, 2020 | -13.98M |
| September 30, 2020 | -18.80M |
| June 30, 2020 | -17.84M |
| Date | Value |
|---|---|
| March 31, 2020 | -23.12M |
| December 31, 2019 | -18.96M |
| September 30, 2019 | -14.43M |
| June 30, 2019 | -11.43M |
| March 31, 2019 | -9.139M |
| December 31, 2018 | -8.673M |
| September 30, 2018 | -9.179M |
| June 30, 2018 | -11.62M |
| March 31, 2018 | -13.61M |
| December 31, 2017 | -15.26M |
| September 30, 2017 | -13.87M |
| June 30, 2017 | -11.01M |
| March 31, 2017 | -7.786M |
| December 31, 2016 | -7.607M |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | -21.95M |
| June 30, 2015 | -16.23M |
| March 31, 2015 | -15.53M |
| December 31, 2014 | -16.38M |
| September 30, 2014 | -11.72M |
| June 30, 2014 | -11.23M |
| March 31, 2014 | -11.20M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| PD-Rx Pharmaceuticals, Inc. | -- |
| Medical Marijuana, Inc. | -0.3957M |
| Acro Biomedical Co. Ltd. | -0.1401M |
| Stella Diagnostics, Inc. | -2.365M |
| ZeroStack Corp. | -5.442M |